But how? Understanding the mode of action of a probiotic in the management of IBS symptoms.

0.5 CPD learning hours

But how? Understanding the mode of action of a probiotic in the management of IBS symptoms.

Professor Eamonn Quigley currently resides in Houston Methodist Hospital as head of its Gastroenterology and Hepatology division. He has previously been president of both the American College of Gastroenterology and the World Gastroenterology Organisation, and is internationally known for his research on gastrointestinal motility disorders, IBS and the gut microbiome.

Begin learning

​Learning Objectives:

  1. Understand the importance of the gut microbiome, and its significance in the management of the symptoms of IBS
  2. Understand the specific modes of action of the Bifidobacterium longum 35624® probiotic strain
  3. Understand the relationships between the modes of action of Bifidobacterium longum 35624® and clinical outcomes of individuals with symptoms of IBS after receiving this probiotic strain

Recommended for you…

CPD e-learning

Probiotics & Irritable Bowel Syndrome

0.5 CPD learning hours

CPD e-learning

Probiotics – Clinical & Real-World Evidence in IBS

1 CPD learning hour

Webinar on Demand

Bifidobacterium longum 35624™ , IBS severity and quality of life. With Prof Jean-Marc Sabate

0.5 CPD learning hours

Clinical Summary

Gut Health & the 35624™ Probiotic Strain

~5 minute read

We use cookies to ensure that we give you the best experience on our website. Please confirm you are happy to continue.

Accept